Next Generation Communication Technologies Market to Cross USD 200 Billion by 2022
Nov 14, 2016 14:00 pm UTC| Business
Hyderabad, Nov. 14, 2016 -- The report “Next Generation Communication Technologies Market - Wireless Communication (Wimax 2.1, Wi-Fi 802.11 ac, 4G LTE, Others) By End-User (Telecommunication, Consumer Electronics,...
Till Capital Announces Q3 2016 Results, Appoints Tilton and Rohlinger to Board
Nov 14, 2016 14:00 pm UTC| Business
HAMILTON, Bermuda, Nov. 14, 2016 -- Till Capital Ltd. (Nasdaq:TIL) (TSX-V:TIL) (“Till”) reports the filing on November 14, 2016 of its financial statements for the third quarter of 2016. Till is pleased to report that...
Alaska Airlines to Fly Today on Gevo’s Cellulosic Renewable Alcohol to Jet Fuel
Nov 14, 2016 14:00 pm UTC| Business
ENGLEWOOD, Colo., Nov. 14, 2016 -- Gevo, Inc. (NASDAQ:GEVO), announced that the first commercial flight using Gevo’s cellulosic renewable alcohol to jet fuel (ATJ) is expected to take place today originating in Seattle...
Nov 14, 2016 14:00 pm UTC| Business
Gift set offers guest first-ever chance to purchase the Company’s famous spice blend and hot sauce; The Company also announces the return of its Holiday Gift Card Promotion, where a $5 Gift Giver Bonus Card comes with...
Nov 14, 2016 14:00 pm UTC| Business
VERNON, Calif., Nov. 14, 2016 -- QFX, Inc. is very pleased to announce the introduction of exciting new products for 2017. All of these new products will be formally introduced at the January 2017 CES in Las Vegas and...
Mateon Provides Corporate Update and Reports Third Quarter 2016 Financial Results
Nov 14, 2016 14:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2016 -- Mateon Therapeutics, Inc. (Nasdaq:MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of orphan oncology indications, today...
Argos Therapeutics Participating in Strategies for an HIV Cure 2016 Meeting
Nov 14, 2016 14:00 pm UTC| Business
DURHAM, N.C., Nov. 14, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis®...